Ayesha Azhar, M. A. Taimuri, M. O. Oduoye, Mahnoor R. Hashmi, Hamna M. Tarar, Rooja Zubair, Tooba Ali
{"title":"巴基斯坦治疗产后抑郁症的 Zurzuvae（祖拉诺龙","authors":"Ayesha Azhar, M. A. Taimuri, M. O. Oduoye, Mahnoor R. Hashmi, Hamna M. Tarar, Rooja Zubair, Tooba Ali","doi":"10.1097/gh9.0000000000000415","DOIUrl":null,"url":null,"abstract":"Postpartum depression (PPD) is a condition that affects some women after giving birth, characterized by feelings of sadness, hopelessness, and emotional distress. Around 30% of Pakistani women suffer from PPD and although multiple treatment options are available, none of these are feasible for Pakistan, a lower-middle-income country with a subpar healthcare system. In August 2023, the Food and Drug Administration (FDA) approved Zurzuvae (zuranolone), the first oral medication for the treatment of PPD. As a low-cost, self-administered oral drug, independent of the need for a healthcare professional, Zuranolone emerges as an efficacious and long-term approach to address PPD in Pakistan.","PeriodicalId":306111,"journal":{"name":"International Journal of Surgery: Global Health","volume":"35 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Zurzuvae (zuranolone) for postpartum depression in Pakistan\",\"authors\":\"Ayesha Azhar, M. A. Taimuri, M. O. Oduoye, Mahnoor R. Hashmi, Hamna M. Tarar, Rooja Zubair, Tooba Ali\",\"doi\":\"10.1097/gh9.0000000000000415\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Postpartum depression (PPD) is a condition that affects some women after giving birth, characterized by feelings of sadness, hopelessness, and emotional distress. Around 30% of Pakistani women suffer from PPD and although multiple treatment options are available, none of these are feasible for Pakistan, a lower-middle-income country with a subpar healthcare system. In August 2023, the Food and Drug Administration (FDA) approved Zurzuvae (zuranolone), the first oral medication for the treatment of PPD. As a low-cost, self-administered oral drug, independent of the need for a healthcare professional, Zuranolone emerges as an efficacious and long-term approach to address PPD in Pakistan.\",\"PeriodicalId\":306111,\"journal\":{\"name\":\"International Journal of Surgery: Global Health\",\"volume\":\"35 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Surgery: Global Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/gh9.0000000000000415\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Surgery: Global Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/gh9.0000000000000415","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Zurzuvae (zuranolone) for postpartum depression in Pakistan
Postpartum depression (PPD) is a condition that affects some women after giving birth, characterized by feelings of sadness, hopelessness, and emotional distress. Around 30% of Pakistani women suffer from PPD and although multiple treatment options are available, none of these are feasible for Pakistan, a lower-middle-income country with a subpar healthcare system. In August 2023, the Food and Drug Administration (FDA) approved Zurzuvae (zuranolone), the first oral medication for the treatment of PPD. As a low-cost, self-administered oral drug, independent of the need for a healthcare professional, Zuranolone emerges as an efficacious and long-term approach to address PPD in Pakistan.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
